| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activated partial thromboplastin time: results of a case–control study evaluating six commercial reagents in assessing the risk of venous thromboembolism
|
TRIPODI, A.
|
|
|
4 |
6 |
p. 1407-1409
|
artikel
|
| 2 |
Activated partial thromboplastin time: results of a case–control study evaluating six commercial reagents in assessing the risk of venous thromboembolism
|
TRIPODI, A.
|
|
2006
|
4 |
6 |
p. 1407-1409
|
artikel
|
| 3 |
A genome‐wide linkage scan for homocysteine levels suggests three regions of interest
|
VERMEULEN, S.H.H.M.
|
|
|
4 |
6 |
p. 1303-1307
|
artikel
|
| 4 |
A genome-wide linkage scan for homocysteine levels suggests three regions of interest
|
VERMEULEN, S. H. H. M.
|
|
2006
|
4 |
6 |
p. 1303-1307
|
artikel
|
| 5 |
Announcements
|
|
|
|
4 |
6 |
p. 1441
|
artikel
|
| 6 |
Announcements
|
|
|
2006
|
4 |
6 |
p. 1441
|
artikel
|
| 7 |
Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin‐treated patients
|
OHMORI, T.
|
|
|
4 |
6 |
p. 1271-1278
|
artikel
|
| 8 |
Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients
|
OHMORI, T.
|
|
2006
|
4 |
6 |
p. 1271-1278
|
artikel
|
| 9 |
Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study
|
REINER, A.P.
|
|
|
4 |
6 |
p. 1279-1287
|
artikel
|
| 10 |
Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study
|
REINER, A. P.
|
|
2006
|
4 |
6 |
p. 1279-1287
|
artikel
|
| 11 |
A tale of two societies
|
MEDCALF, R.L.
|
|
|
4 |
6 |
p. 1173-1174
|
artikel
|
| 12 |
A tale of two societies
|
MEDCALF, R. L.
|
|
2006
|
4 |
6 |
p. 1173-1174
|
artikel
|
| 13 |
Can anticoagulant treatment be tailored with biomarkers in patients with venous thromboembolism?
|
KAMPHUISEN, P.W.
|
|
|
4 |
6 |
p. 1206-1207
|
artikel
|
| 14 |
Can anticoagulant treatment be tailored with biomarkers in patients with venous thromboembolism?
|
KAMPHUISEN, P. W.
|
|
2006
|
4 |
6 |
p. 1206-1207
|
artikel
|
| 15 |
Can the PFA‐100® be modified to detect P2Y12 inhibition?
|
PIDCOCK, M.
|
|
|
4 |
6 |
p. 1424-1426
|
artikel
|
| 16 |
Can the PFA-100® be modified to detect P2Y12 inhibition?
|
PIDCOCK, M.
|
|
2006
|
4 |
6 |
p. 1424-1426
|
artikel
|
| 17 |
Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome
|
SIMAK, J.
|
|
|
4 |
6 |
p. 1296-1302
|
artikel
|
| 18 |
Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome
|
SIMAK, J.
|
|
2006
|
4 |
6 |
p. 1296-1302
|
artikel
|
| 19 |
Clinical outcomes with unfractionated heparin or low‐molecular‐weight heparin as bridging therapy in patients on long‐term oral anticoagulants: the REGIMEN registry 1
|
SPYROPOULOS, A.C.
|
|
|
4 |
6 |
p. 1246-1252
|
artikel
|
| 20 |
Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry 1
|
SPYROPOULOS, A. C.
|
|
2006
|
4 |
6 |
p. 1246-1252
|
artikel
|
| 21 |
Critical role of ADP interaction with P2Y12 receptor in the maintenance of α IIb β 3 activation: association with Rap1B activation
|
KAMAE, T.
|
|
|
4 |
6 |
p. 1379-1387
|
artikel
|
| 22 |
Critical role of ADP interaction with P2Y12 receptor in the maintenance of αIIbβ3 activation: association with Rap1B activation
|
KAMAE, T.
|
|
2006
|
4 |
6 |
p. 1379-1387
|
artikel
|
| 23 |
D‐dimer, factor VIII coagulant activity, low‐intensity warfarin and the risk of recurrent venous thromboembolism
|
SHRIVASTAVA, S.
|
|
|
4 |
6 |
p. 1208-1214
|
artikel
|
| 24 |
D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism
|
SHRIVASTAVA, S.
|
|
2006
|
4 |
6 |
p. 1208-1214
|
artikel
|
| 25 |
Definition of novel GP6 polymorphisms and major difference in haplotype frequencies between populations by a combination of in‐depth exon resequencing and genotyping with tag single nucleotide polymorphisms
|
WATKINS, N.A.
|
|
|
4 |
6 |
p. 1197-1205
|
artikel
|
| 26 |
Definition of novel GP6 polymorphisms and major difference in haplotype frequencies between populations by a combination of in-depth exon resequencing and genotyping with tag single nucleotide polymorphisms
|
WATKINS, N. A.
|
|
2006
|
4 |
6 |
p. 1197-1205
|
artikel
|
| 27 |
Elevated levels of soluble fibrin or D‐dimer indicate high risk of thrombosis
|
WADA, H.
|
|
|
4 |
6 |
p. 1253-1258
|
artikel
|
| 28 |
Elevated levels of soluble fibrin or D-dimer indicate high risk of thrombosis
|
WADA, H.
|
|
2006
|
4 |
6 |
p. 1253-1258
|
artikel
|
| 29 |
Extra‐virgin vs. refined olive oil on postprandial hemostatic markers in healthy subjects
|
PACHECO, Y.M.
|
|
|
4 |
6 |
p. 1421-1422
|
artikel
|
| 30 |
Extra-virgin vs. refined olive oil on postprandial hemostatic markers in healthy subjects
|
PACHECO, Y. M.
|
|
2006
|
4 |
6 |
p. 1421-1422
|
artikel
|
| 31 |
Factor V C2 domain contains a major thrombin‐binding site responsible for thrombin‐catalyzed factor V activation
|
SUZUKI, H.
|
|
|
4 |
6 |
p. 1354-1360
|
artikel
|
| 32 |
Factor V C2 domain contains a major thrombin-binding site responsible for thrombin-catalyzed factor V activation
|
SUZUKI, H.
|
|
2006
|
4 |
6 |
p. 1354-1360
|
artikel
|
| 33 |
Factor Xa protects cultured hippocampal neurons from glutamate toxicity
|
STRUKOVA, S.
|
|
|
4 |
6 |
p. 1409-1410
|
artikel
|
| 34 |
Factor Xa protects cultured hippocampal neurons from glutamate toxicity
|
STRUKOVA, S.
|
|
2006
|
4 |
6 |
p. 1409-1410
|
artikel
|
| 35 |
Forthcoming articles in the July issue
|
|
|
|
4 |
6 |
p. xiv
|
artikel
|
| 36 |
Forthcoming articles in the July issue
|
|
|
2006
|
4 |
6 |
p. xiv
|
artikel
|
| 37 |
Helper‐dependent adenoviral gene therapy mediates long‐term correction of the clotting defect in the canine hemophilia A model
|
McCORMACK JR, W.M.
|
|
|
4 |
6 |
p. 1218-1225
|
artikel
|
| 38 |
Helper-dependent adenoviral gene therapy mediates long-term correction of the clotting defect in the canine hemophilia A model
|
M cCORMACK , W. M.
|
|
2006
|
4 |
6 |
p. 1218-1225
|
artikel
|
| 39 |
Human endothelial cells synthesize and release ADAMTS-13
|
TURNER, N.
|
|
2006
|
4 |
6 |
p. 1396-1404
|
artikel
|
| 40 |
Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation 1
|
MAUGERI, N.
|
|
|
4 |
6 |
p. 1323-1330
|
artikel
|
| 41 |
Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation 1
|
MAUGERI, N.
|
|
2006
|
4 |
6 |
p. 1323-1330
|
artikel
|
| 42 |
Incorrect use of thromboprophylaxis for venous thromboembolism in medical and surgical patients: results of a multicentric, observational and cross‐sectional study in Brazil
|
DEHEINZELIN, D.
|
|
|
4 |
6 |
p. 1266-1270
|
artikel
|
| 43 |
Incorrect use of thromboprophylaxis for venous thromboembolism in medical and surgical patients: results of a multicentric, observational and cross-sectional study in Brazil
|
DEHEINZELIN, D.
|
|
2006
|
4 |
6 |
p. 1266-1270
|
artikel
|
| 44 |
Increase in plasma plasminogen activators inhibitor type 1 concentration after fibrinolytic treatment in patients with acute myocardial infarction is associated with 4G/5G polymorphism of PAI‐1 gene
|
MLYNARSKA, A.
|
|
|
4 |
6 |
p. 1361-1366
|
artikel
|
| 45 |
Increase in plasma plasminogen activators inhibitor type 1 concentration after fibrinolytic treatment in patients with acute myocardial infarction is associated with 4G/5G polymorphism of PAI-1 gene
|
MLYNARSKA, A.
|
|
2006
|
4 |
6 |
p. 1361-1366
|
artikel
|
| 46 |
International collaborative study for the calibration of a proposed international standard for thromboplastin, rabbit, plain
|
CHANTARANGKUL, V.
|
|
2006
|
4 |
6 |
p. 1339-1345
|
artikel
|
| 47 |
Intracellular readthrough of nonsense mutations by aminoglycosides in coagulation factor VII
|
PINOTTI, M.
|
|
|
4 |
6 |
p. 1308-1314
|
artikel
|
| 48 |
Intracellular readthrough of nonsense mutations by aminoglycosides in coagulation factor VII
|
PINOTTI, M.
|
|
2006
|
4 |
6 |
p. 1308-1314
|
artikel
|
| 49 |
Intrinsic stability and functional properties of disulfide bond‐stabilized coagulation factor VIIIa variants
|
GALE, A.J.
|
|
|
4 |
6 |
p. 1315-1322
|
artikel
|
| 50 |
Intrinsic stability and functional properties of disulfide bond-stabilized coagulation factor VIIIa variants
|
GALE, A. J.
|
|
2006
|
4 |
6 |
p. 1315-1322
|
artikel
|
| 51 |
Low incidence of venographically detected deep vein thrombosis after knee arthroscopy without thromboprophylaxis: a prospective cohort study
|
ETTEMA, H.B.
|
|
|
4 |
6 |
p. 1411-1413
|
artikel
|
| 52 |
Low incidence of venographically detected deep vein thrombosis after knee arthroscopy without thromboprophylaxis: a prospective cohort study
|
ETTEMA, H. B.
|
|
2006
|
4 |
6 |
p. 1411-1413
|
artikel
|
| 53 |
Molecular evolution caught in action: gene duplication and evolution of molecular isoforms of prothrombin activators in Pseudonaja textilis (brown snake)
|
REZA, M.A.
|
|
|
4 |
6 |
p. 1346-1353
|
artikel
|
| 54 |
Molecular evolution caught in action: gene duplication and evolution of molecular isoforms of prothrombin activators in Pseudonaja textilis (brown snake)
|
REZA, M. A.
|
|
2006
|
4 |
6 |
p. 1346-1353
|
artikel
|
| 55 |
More on: platelet function analyzer (PFA)‐100® closure time in the evaluation of platelet disorders and platelet function
|
KOSCIELNY, J.
|
|
|
4 |
6 |
p. 1426-1427
|
artikel
|
| 56 |
More on: platelet function analyzer (PFA)-100® closure time in the evaluation of platelet disorders and platelet function
|
KOSCIELNY, J.
|
|
2006
|
4 |
6 |
p. 1426-1427
|
artikel
|
| 57 |
Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study
|
CANONICO, M.
|
|
|
4 |
6 |
p. 1259-1265
|
artikel
|
| 58 |
Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study
|
CANONICO, M.
|
|
2006
|
4 |
6 |
p. 1259-1265
|
artikel
|
| 59 |
Parachutes and prophylaxis: they both work!
|
WHITE II, G.C.
|
|
|
4 |
6 |
p. 1226-1227
|
artikel
|
| 60 |
Parachutes and prophylaxis: they both work!
|
WHITE, G. C.
|
|
2006
|
4 |
6 |
p. 1226-1227
|
artikel
|
| 61 |
Patterns of changes of anti‐ADAMTS13 after plasma exchange
|
MANNUCCI, P.M.
|
|
|
4 |
6 |
p. 1405-1406
|
artikel
|
| 62 |
Patterns of changes of anti-ADAMTS13 after plasma exchange
|
MANNUCCI, P. M.
|
|
2006
|
4 |
6 |
p. 1405-1406
|
artikel
|
| 63 |
Pharmacoeconomics of anticoagulation therapy for stroke prevention in atrial fibrillation: a review
|
SZUCS, T.D.
|
|
|
4 |
6 |
p. 1180-1185
|
artikel
|
| 64 |
Pharmacoeconomics of anticoagulation therapy for stroke prevention in atrial fibrillation: a review
|
SZUCS, T. D.
|
|
2006
|
4 |
6 |
p. 1180-1185
|
artikel
|
| 65 |
Plasminogen and plasmin activity in patients with coronary artery disease
|
DRINANE, M.C.
|
|
|
4 |
6 |
p. 1288-1295
|
artikel
|
| 66 |
Plasminogen and plasmin activity in patients with coronary artery disease
|
DRINANE, M. C.
|
|
2006
|
4 |
6 |
p. 1288-1295
|
artikel
|
| 67 |
Platelet function analyzer (PFA)‐100® closure time in the evaluation of platelet disorders and platelet function – a rebuttal
|
KRATZER, M.A.A.
|
|
|
4 |
6 |
p. 1429-1431
|
artikel
|
| 68 |
Platelet function analyzer (PFA)-100® closure time in the evaluation of platelet disorders and platelet function – a rebuttal
|
KRATZER, M. A. A.
|
|
2006
|
4 |
6 |
p. 1429-1431
|
artikel
|
| 69 |
Platelet function analyzer (PFA)‐100® closure time in the evaluation of platelet disorders and platelet function: reply to a rebuttal
|
HAYWARD, C.P.M.
|
|
|
4 |
6 |
p. 1432
|
artikel
|
| 70 |
Platelet function analyzer (PFA)‐100®closure time in the evaluation of platelet disorders and platelet function: reply to a rebuttal
|
HAYWARD, C.P.M.
|
|
|
4 |
6 |
p. 1433-1434
|
artikel
|
| 71 |
Platelet function analyzer (PFA)-100® closure time in the evaluation of platelet disorders and platelet function: reply to a rebuttal
|
HAYWARD, C. P. M.
|
|
2006
|
4 |
6 |
p. 1432
|
artikel
|
| 72 |
Platelet function analyzer (PFA)-100®closure time in the evaluation of platelet disorders and platelet function: reply to a rebuttal
|
HAYWARD, C. P. M.
|
|
2006
|
4 |
6 |
p. 1433-1434
|
artikel
|
| 73 |
Platelet function analyzer (PFA‐100)TM closure time in the evaluation of platelet disorders and platelet function: a rebuttal
|
SEREBRUANY, V.L.
|
|
|
4 |
6 |
p. 1428-1429
|
artikel
|
| 74 |
Platelet function analyzer (PFA-100)TM closure time in the evaluation of platelet disorders and platelet function: a rebuttal
|
SEREBRUANY, V. L.
|
|
2006
|
4 |
6 |
p. 1428-1429
|
artikel
|
| 75 |
Platelet septin complexes form rings and associate with the microtubular network
|
MARTÍNEZ, C.
|
|
|
4 |
6 |
p. 1388-1395
|
artikel
|
| 76 |
Platelet septin complexes form rings and associate with the microtubular network
|
MARTÍNEZ, C.
|
|
2006
|
4 |
6 |
p. 1388-1395
|
artikel
|
| 77 |
Polymorphisms and platelet genotyping: the shape of things to come
|
NURDEN, A.T.
|
|
|
4 |
6 |
p. 1194-1196
|
artikel
|
| 78 |
Polymorphisms and platelet genotyping: the shape of things to come
|
NURDEN, A. T.
|
|
2006
|
4 |
6 |
p. 1194-1196
|
artikel
|
| 79 |
Regulation of endogenous tissue-type plasminogen activator expression is modulated by the −7351C>T enhancer polymorphism
|
TjÄRNLUND-WOLF, A.
|
|
2006
|
4 |
6 |
p. 1414-1418
|
artikel
|
| 80 |
Regulation of endogenous tissue‐type plasminogen activator expression is modulated by the −7351C>T enhancer polymorphism
|
TjÄRNLUND‐WOLF, A.
|
|
|
4 |
6 |
p. 1414-1418
|
artikel
|
| 81 |
Remembrances of factor VIII. Part 2: the path to mutation discovery
|
GITSCHIER, J.
|
|
|
4 |
6 |
p. 1175-1179
|
artikel
|
| 82 |
Remembrances of factor VIII. Part 2: the path to mutation discovery
|
GITSCHIER, J.
|
|
2006
|
4 |
6 |
p. 1175-1179
|
artikel
|
| 83 |
Screening for children from families with Rendu–Osler–Weber disease: from geneticist to clinician
|
GIORDANO, P.
|
|
|
4 |
6 |
p. 1237-1245
|
artikel
|
| 84 |
Screening for children from families with Rendu–Osler–Weber disease: from geneticist to clinician
|
GIORDANO, P.
|
|
2006
|
4 |
6 |
p. 1237-1245
|
artikel
|
| 85 |
Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study
|
FELDMAN, B.M.
|
|
|
4 |
6 |
p. 1228-1236
|
artikel
|
| 86 |
Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study
|
FELDMAN, B. M.
|
|
2006
|
4 |
6 |
p. 1228-1236
|
artikel
|
| 87 |
Talking about…
|
BRUTTOMESSO, G.
|
|
|
4 |
6 |
p. 1438-1440
|
artikel
|
| 88 |
Talking about…
|
BRUTTOMESSO, G.
|
|
2006
|
4 |
6 |
p. 1438-1440
|
artikel
|
| 89 |
β‐Thalassemia intermedia and pregnancy: should we anticoagulate?
|
NASSAR, A.H.
|
|
|
4 |
6 |
p. 1413-1414
|
artikel
|
| 90 |
β-Thalassemia intermedia and pregnancy: should we anticoagulate?
|
NASSAR, A. H.
|
|
2006
|
4 |
6 |
p. 1413-1414
|
artikel
|
| 91 |
The impact of simvastatin on warfarin disposition and dose requirements
|
SCONCE, E.A.
|
|
|
4 |
6 |
p. 1422-1424
|
artikel
|
| 92 |
The impact of simvastatin on warfarin disposition and dose requirements
|
SCONCE, E. A.
|
|
2006
|
4 |
6 |
p. 1422-1424
|
artikel
|
| 93 |
The limits of simulation of the clotting system
|
WAGENVOORD, R.
|
|
|
4 |
6 |
p. 1331-1338
|
artikel
|
| 94 |
The limits of simulation of the clotting system
|
WAGENVOORD, R.
|
|
2006
|
4 |
6 |
p. 1331-1338
|
artikel
|
| 95 |
The reactivity of paired plasma and serum samples are comparable in the anticardiolipin and anti‐β2‐glycoprotein‐1 ELISAs: a rebuttal
|
WONG, R.C.W.
|
|
|
4 |
6 |
p. 1434-1435
|
artikel
|
| 96 |
The reactivity of paired plasma and serum samples are comparable in the anticardiolipin and anti-β2-glycoprotein-1 ELISAs: a rebuttal
|
WONG, R. C. W.
|
|
2006
|
4 |
6 |
p. 1434-1435
|
artikel
|
| 97 |
The reactivity of paired plasma and serum samples are comparable in the anticardiolipin and anti‐β2‐glycoprotein‐1 ELISAs. Reply to a rebuttal
|
LEWIS, D.A.
|
|
|
4 |
6 |
p. 1435-1437
|
artikel
|
| 98 |
The reactivity of paired plasma and serum samples are comparable in the anticardiolipin and anti-β2-glycoprotein-1 ELISAs. Reply to a rebuttal
|
LEWIS, D. A.
|
|
2006
|
4 |
6 |
p. 1435-1437
|
artikel
|
| 99 |
The relationship between ABO blood group and the risk of bleeding during vitamin K antagonist treatment
|
GARCIA, A.A.
|
|
|
4 |
6 |
p. 1418-1420
|
artikel
|
| 100 |
The relationship between ABO blood group and the risk of bleeding during vitamin K antagonist treatment
|
GARCIA, A. A.
|
|
2006
|
4 |
6 |
p. 1418-1420
|
artikel
|
| 101 |
Toward gene therapy for hemophilia A with novel adenoviral vectors: successes and limitations in canine models
|
ARRUDA, V.R.
|
|
|
4 |
6 |
p. 1215-1217
|
artikel
|
| 102 |
Toward gene therapy for hemophilia A with novel adenoviral vectors: successes and limitations in canine models
|
ARRUDA, V. R.
|
|
2006
|
4 |
6 |
p. 1215-1217
|
artikel
|
| 103 |
von Willebrand factor, endothelial dysfunction, and cardiovascular disease
|
VISCHER, U.M.
|
|
|
4 |
6 |
p. 1186-1193
|
artikel
|
| 104 |
von Willebrand factor, endothelial dysfunction, and cardiovascular disease
|
VISCHER, U. M.
|
|
2006
|
4 |
6 |
p. 1186-1193
|
artikel
|
| 105 |
von Willebrand factor mediates platelet spreading through glycoprotein Ib and αIIb β 3 in the presence of botrocetin and ristocetin, respectively
|
MCCARTY, O.J.T.
|
|
|
4 |
6 |
p. 1367-1378
|
artikel
|
| 106 |
von Willebrand factor mediates platelet spreading through glycoprotein Ib and αIIbβ3 in the presence of botrocetin and ristocetin, respectively
|
MCCARTY, O. J. T.
|
|
2006
|
4 |
6 |
p. 1367-1378
|
artikel
|
Tijdschrift beschrijving